RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 13 analysts with an average price target of $253.92. This is a potential upside of $17.33 (7.32%) from yesterday's end of day stock price of $236.59.

ResMed's activity chart (see below) currently has 95 price targets and 124 ratings on display. The stock rating distribution of RMD is 65.52% BUY, 32.76% HOLD and 1.72% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.64% with an average time for these price targets to be met of 102.82 days.

Highest price target for RMD is $290, Lowest price target is $248, average price target is $248.25.

Most recent stock forecast was given by DAVID LOW from JPMORGAN on 24-Apr-2025.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 38 are a BUY (65.52%), 19 are a HOLD (32.76%), 1 are a SELL (1.72%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$290

$54.12 (22.94%)

$286

6 days ago
(24-Apr-2025)

14/18 (77.78%)

$53.9 (22.83%)

310

Hold

$248

$12.12 (5.14%)

$260

6 days ago
(24-Apr-2025)

1/3 (33.33%)

$11.9 (5.04%)

17

Buy

$285

$49.12 (20.82%)

$250

6 days ago
(24-Apr-2025)

5/6 (83.33%)

$48.9 (20.71%)

30

Hold

2 months 30 days ago
(31-Jan-2025)

11/11 (100%)

$-7.67 (-3.15%)

212

Buy

$250

$14.12 (5.99%)

$215

7 months ago
(30-Sep-2024)

11/11 (100%)

$6.95 (2.86%)

115

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 102.82 days on average for the stock forecasts to be realized with a an average price target met ratio 59.64

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

LYANNE HARRISON

Which analyst has the most public recommendations on RMD (ResMed)?

Lyanne Harrison works at BAML and has 17 price targets and 9 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

David Low with highest potential upside - $54.12

Which analyst is the currently most reserved on RMD (ResMed)?

Joanne Wuensch with lowest potential downside - -$115.88

ResMed in the News

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

ResMed RMD shares rallied 3.8% in the last trading session to close at $213. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock’s 11.7% loss over the past four weeks. ResMed scored a strong price increase, on investors’...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?